RSS
7 Dec 2021

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines

Author: admintech | Filed under: Press Release

BOSTON, Dec. 7, 2021 /PRNewswire/ — Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced the completion of an oversubscribed $218 million Series A financing led by OrbiMed Advisors and co-led by SR One…

This entry was posted on Tuesday, December 7th, 2021 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»